PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
Follow PACS
Alert me
PACS Group, Inc. (PACS) Revenue growth
PACS Group, Inc.'s revenue growth over the twelve months to 30 September 2026 was 11.0%, down 18.3 percentage points from fiscal 2025 (29.3%). That is above the Medical Care Facilities industry median of 6.38% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 29.3% | (2.12) |
| FY2024 | 31.4% | 2.97 |
| FY2023 | 28.5% | (79.15) |
| FY2022 | 107.6% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 11.5% | 2.38 |
| Jun 2026 | 9.07% | (2.15) |
| Mar 2026 | 11.2% | (1.21) |
| Dec 2025 | 12.4% | (18.58) |
| 7 more quarters | Free account |
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| LFST LifeStance Health Group, Inc. compare | 22.6% |
| ENSG The Ensign Group, Inc. compare | 17.5% |
| CON Concentra Group Holdings Parent, Inc. compare | 11.8% |
| PACS PACS Group, Inc. | 11.0% |
| UHS Universal Health Services, Inc. compare | 8.00% |
| DVA DaVita Inc. compare | 6.38% |
| CHE Chemed Corporation compare | 5.15% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 4.27% |
| OPCH Option Care Health, Inc. compare | 4.01% |
| Medical Care Facilities industry median | 6.38% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on PACS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Beneish M-score
- The full statement